首页> 外文期刊>Indian journal of Anaesthesia >Time course of psychomotor recovery after intravenous dexmedetomidine infusion as a part of balanced anaesthetic technique: A randomised, double-blind study
【24h】

Time course of psychomotor recovery after intravenous dexmedetomidine infusion as a part of balanced anaesthetic technique: A randomised, double-blind study

机译:静脉注射探测法丙胺输注后的精神运动恢复的时间过程作为平衡麻醉技术的一部分:随机,双盲研究

获取原文
           

摘要

Background and Aims: Dexmedetomidine is a drug that is being widely used as an adjuvant to anaesthesia because of its unique pharmacodynamic and pharmacokinetic properties. We aimed to assess the recovery of psychomotor function from balanced anaesthesia including intravenous dexmedetomidine infusion as adjunct. Methods: Ninety American Society of Anesthesiologists I and II patients were randomised to group D (n = 45), to receive 1 μg/kg of dexmedetomidine loading dose over 10 min, with maintenance infusion of 0.5 μg/kg/h, and group S (n = 45), to receive an equal volume of 0.9% normal saline. Objective parameters were recovery of psychomotor function assessed by Trieger dot test (TDT), digit symbol substitution test (DSST) and intraoperative opioid requirement. the total fentanyl used intraoperatively in the two groups. Statistical analysis was performed using unpaired Student's t-test, Chi-squareor Fisher's exact test. Results: Psychomotor recovery assessed by TDT showed statistically significant early recovery in group D compared with group S. This was seen in the maximum distance of dots missed at 30 min, 60 min, 90 min and 120 min as well as in the average distance of dots missed at identical time points. Similarly, DSST revealed early recovery at 30 min (12.4 ± 5.3 vs. 10.4 ± 3.9 P = 0.04) postoperative interval but not at other time intervals. There was significant decrease in the intraoperative opioid requirement in group D compared with group S. Conclusion: The addition of dexmedetomidine to balanced anaesthetic technique significantly hastened the psychomotor recovery compared with placebo.
机译:背景和目的:Dexmedetomidine是一种药物,其被广泛用作麻醉,因为其独特的药效学和药代动力学性质。我们的旨在评估从平衡麻醉中的精神运动功能的恢复,包括静脉内右传嘌呤输注作为辅助。方法:九十美洲麻醉学家I和II患者随机分配给D组(n = 45),以在10分钟内接收1μg/ kg右甲酰胺加载剂量,维持输注0.5μg/ kg / h,群体(n = 45),接受相等体积的0.9%甘盐。客观参数是通过Trieger点测试(TDT),数字符号替代测试(DSST)和术中阿片类药物要求评估的精神仪函数的回收。在两组中术中使用的总芬太尼。使用未配对的学生的T检验进行统计分析,Chi-Scansor Fisher的确切测试。结果:TDT评估的精神疗程恢复显示D组D统计上显着的早期恢复与组。这是在30分钟的最大距离下,60分钟,90分钟和120分钟以及平均距离的最大距离点错过相同的时间点。类似地,DSST在术后间隔内(12.4±5.3与10.4±3.9 p = 0.04)显示早期回收率,但不适用于其他时间间隔。 D组术中阿片类药物需求的显着降低与S群相比。结论:与安慰剂相比,添加了右丁梅多咪啶以平衡麻醉技术明显加速了精神运动恢复。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号